EROCK <EROC.N>: BofA Global Research Raises Price Objective to $19.00 From $16.00
EROC•Related News
Bragg Gaming FY26 Q2 net loss widens to EUR 2.88 million; revenue drops 12% to EUR 22.9 million
BRAG•
Yesway Reports Second Quarter 2026 Financial Results
YSWY•
Definium Therapeutics Inc <DFTX.O>: Jonestrading raises target price to $90 from $74
DFTX•
Cabaletta Bio Q2 FY26 net loss narrows 11.69% to $51.02 million; R&D expenses rise 18.06% to $44.43 million
CABA•
Cellebrite Appoints Shiven Ramji Chief Executive Officer, Succeeding Thomas E. Hogan
CLBT•